M Hrubisko
About
In The Last Decade
M Hrubisko
23 papers receiving 259 citations
Peers
Comparison fields: 5 of 64
- Oncology 157
- Hematology 102
- Molecular Biology 61
- Radiology, Nuclear Medicine and Imaging 48
- Genetics 39
Countries citing papers authored by M Hrubisko
This map shows the geographic impact of M Hrubisko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hrubisko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hrubisko more than expected).
Fields of papers citing papers by M Hrubisko
This network shows the impact of papers produced by M Hrubisko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hrubisko. The network helps show where M Hrubisko may publish in the future.
Co-authorship network of co-authors of M Hrubisko
This figure shows the co-authorship network connecting the top 25 collaborators of M Hrubisko. A scholar is included among the top collaborators of M Hrubisko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hrubisko. M Hrubisko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 10 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 49 | |
| 7 | [Autologous stem cell transplantation in a patient with juvenile chronic arthritis]. | 2 |
| 8 | Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line. | 4 |
| 9 | 33 | |
| 10 | 7 | |
| 11 | Electrophoretic analysis of DNA modifications induced by cis- and trans-diamminedichloroplatinum (II) during heat-denaturation of conformation isomers of pBR322 DNA. | 1 |
| 12 | Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. | 0 |
| 13 | Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives. | 2 |
| 14 | Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. | 1 |
| 15 | Comparison of the effectivity of two diaminocyclohexane Pt-complexes. | 2 |
| 16 | Drug resistance induction and cross-resistance studies with Pt-complexes. | 6 |
| 17 | In vivo and in vitro effectivity of some platinum complexes. | 2 |
| 18 | 11 | |
| 19 | Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes. | 2 |
| 20 | [Variant A1-Oh]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.